The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback